PACS Group Inc header image

PACS Group Inc

PACS

Equity

ISIN null / Valor 133777092

New York Stock Exchange, Inc (2026-11-09)
USD 48.77-1.67%

PACS Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

PACS Group, Inc. (PACS) is a holding company that has significantly expanded its footprint in the healthcare sector, specifically focusing on the post-acute care industry since its inception in 2013. Starting with just two skilled nursing facilities, PACS has grown into a substantial network, now encompassing over 200 facilities across nine states. The company's growth strategy involves investing in post-acute care facilities, healthcare professionals, and ancillary services to provide comprehensive care. PACS emphasizes a model that combines the benefits of a national support network with the autonomy of local decision-making in its operations. As of now, PACS and its affiliates manage 218 facilities, employing over 32,000 staff members, and cater to the daily needs of more than 20,000 patients and residents. This expansion reflects PACS's commitment to delivering mission-driven care and addressing the growing demand for post-acute healthcare services in the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

296%1Y
%3Y
%5Y

Performance

81.1%1Y
78.4%3Y
78.4%5Y

Volatility

Market cap

7741 M

Market cap (USD)

Daily traded volume (Shares)

988,326

Daily traded volume (Shares)

1 day high/low

12.93 / 12.55

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Cipla Ltd
Cipla Ltd Cipla Ltd Valor: 1850620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.21%INR 1,406.00
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC Valor: 2324471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.52%GBP 16.25
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited Valor: 12029898
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%INR 1,905.00
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%CHF 4.19
Pharma Mar SA
Pharma Mar SA Pharma Mar SA Valor: 56130572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.06%EUR 67.40
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.32%SEK 496.60
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.20%INR 581.80
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited AstraZeneca Pharma India Limited Valor: 2593348
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.95%INR 6,512.20
Lupin Limited
Lupin Limited Lupin Limited Valor: 11598960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.11%INR 2,012.00
Abbott India Limited
Abbott India Limited Abbott India Limited Valor: 561999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%INR 26,648.25